EDTA K2/EDTA K3

紫頭管中(zhōng)的抗凝劑爲 EDTA 鹽。國際血液委員(yuán)會推薦使用抗凝效率較高 , 穩定性更強 , ph 值與血液相對接近的乙二胺四乙酸 · 二鉀(EDTA.K2)。 獨一(yī)無二的内壁仿生(shēng)活性膜處理 , 有效地維持了血小(xiǎo)闆的活性穩定。微噴霧技術的運用降低 了因血小(xiǎo)闆黏附與聚集而發生(shēng)血小(xiǎo)闆損失和凝血的風險 ,嚴格的微粒污染控制工(gōng)藝杜絕了微粒污染對檢驗結果的影響。 Purple cap use EDTA salt as anticoagulant. ICSH recommends using EDTA.K2, which is with higher anticoagulation efficiency, stronger stability and relatively closer ph value with blood. The unique imitated life film treatment on its inner wall can effectively maintain the active stability of platelet. The application of micro atomizing technology has lowered the hazard of platelet loss and blood coagulation caused by platelet adherence and gathering. And the rigorous particle pollution control technology has completely eradicated the impact on test result caused by particle pollution.